PerceptiMed's ScripClip system features clear plastic hanging bags with LED lights embedded in each bag’s handle, which is meant to make will-call pick up faster.
The Association for Accessible Medicines has told members of Congress that the Hatch-Waxman Integrity Act of 2019 would decrease patient access to generics and biosimilars.
The pilot will inform the development of the enhanced electronic, interoperable track-and-trace system for industry set to go into effect in 2023 as part of the Drug Supply Chain Security Act, the agency said.
The Food and Drug Administration has cleared Lupin's generic Adcirca, which had a market value of about $474.3 million for the year ended December 2018.